Evaluation of ovarian reserve in women with psoriasis

Gynecol Endocrinol. 2019 Jul;35(7):608-611. doi: 10.1080/09513590.2018.1563884. Epub 2019 Jan 30.

Abstract

The aim of this study is to evaluate ovarian reserve in women with psoriasis. Thirty-six women with psoriasis and 36 healthy women were enrolled in this prospective study. On day 3 of the menstrual cycle, blood samples for AMH and other hormones were collected. On the same day, antral follicle count (AFC), and ovarian volumes were measured. A multiple regression analysis was carried out to examine the contribution of factors to the serum AMH levels in patients with psoriasis. The serum AMH levels and ovarian volumes were lower in the psoriasis group than in the control group (1.85 ± 1.13 ng/ml vs 2.46 ± 1.21 ng/ml, p = .029 and 10.43 ± 3.08 cm3 vs 11.93 ± 3.01 cm3, p = .038). However, the mean AFC between the two groups was not significantly different. The psoriasis area severity index (PASI) score did not correlate with AMH. On the other hand, the duration of the disease negatively correlated with AMH, total AFC and ovarian volume. In the multiple regression analysis, duration of disease and total AFC were the most significant contributors to the serum AMH levels in patients with psoriasis. Autoimmune diseases may affect ovarian reserve regardless of immunosuppresive treatment. Longitudinal follow-ups regarding reproductive function might be required in women with psoriasis.

Keywords: Ovarian reserve; anti-mullerian hormone; antral follicle count; psoriasis.

MeSH terms

  • Adolescent
  • Adult
  • Anti-Mullerian Hormone / blood*
  • Female
  • Humans
  • Ovarian Follicle / diagnostic imaging*
  • Ovarian Reserve / physiology*
  • Ovary / diagnostic imaging*
  • Prospective Studies
  • Psoriasis / blood*
  • Psoriasis / diagnostic imaging
  • Ultrasonography
  • Young Adult

Substances

  • Anti-Mullerian Hormone